164 related articles for article (PubMed ID: 37003349)
1. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
Zou L; Fang Y; He W
Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
[TBL] [Abstract][Full Text] [Related]
2. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.
Doddaballapur A; Michalik KM; Manavski Y; Lucas T; Houtkooper RH; You X; Chen W; Zeiher AM; Potente M; Dimmeler S; Boon RA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):137-45. PubMed ID: 25359860
[TBL] [Abstract][Full Text] [Related]
3. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
4. Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3.
Robinson AJ; Hopkins GL; Rastogi N; Hodges M; Doyle M; Davies S; Hole PS; Omidvar N; Darley RL; Tonks A
Cancer Res; 2020 Mar; 80(5):937-949. PubMed ID: 31862780
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells.
Ding Q; Wang Q; Ren Y; Zhu HQ; Huang Z
Biochem Cell Biol; 2018 Dec; 96(6):840-846. PubMed ID: 29940130
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma.
Li J; Zhang S; Liao D; Zhang Q; Chen C; Yang X; Jiang D; Pang J
BMC Cancer; 2022 Jan; 22(1):83. PubMed ID: 35057732
[TBL] [Abstract][Full Text] [Related]
7. DT-13 induced apoptosis and promoted differentiation of acute myeloid leukemia cells by activating AMPK-KLF2 pathway.
Wang C; He H; Liu G; Ma H; Li L; Jiang M; Lu Q; Li P; Qi H
Pharmacol Res; 2020 Aug; 158():104864. PubMed ID: 32416217
[TBL] [Abstract][Full Text] [Related]
8. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
Feng Y; Wu L
Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
[TBL] [Abstract][Full Text] [Related]
9. Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
Zhu Y; Lu L; Qiao C; Shan Y; Li H; Qian S; Hong M; Zhao H; Li J; Yang Z; Chen Y
Oncogene; 2018 May; 37(21):2837-2849. PubMed ID: 29511345
[TBL] [Abstract][Full Text] [Related]
10. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis.
Shang Z; Ming X; Wu J; Liu W; Xiao Y
Expert Rev Hematol; 2022 Dec; 15(12):1073-1083. PubMed ID: 35980117
[TBL] [Abstract][Full Text] [Related]
11. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
12. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
[TBL] [Abstract][Full Text] [Related]
13. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract][Full Text] [Related]
14. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
[TBL] [Abstract][Full Text] [Related]
15. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Laha D; Deb M; Das H
Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
[TBL] [Abstract][Full Text] [Related]
16. Targeted metabolomics reveals PFKFB3 as a key target for elemene-mediated inhibition of glycolysis in prostate cancer cells.
Dong XM; Chen L; Wu P; Cheng LH; Wang Y; Yang Y; Zhang Y; Tang WY; Xie T; Zhou JL
Phytomedicine; 2024 Jan; 123():155185. PubMed ID: 38134863
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
Wang J; Li X; Xiao Z; Wang Y; Han Y; Li J; Zhu W; Leng Q; Wen Y; Wen X
FEBS Open Bio; 2019 Oct; 9(10):1798-1807. PubMed ID: 31410981
[TBL] [Abstract][Full Text] [Related]
18. PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT.
Shi WK; Zhu XD; Wang CH; Zhang YY; Cai H; Li XL; Cao MQ; Zhang SZ; Li KS; Sun HC
Cell Death Dis; 2018 Apr; 9(4):428. PubMed ID: 29559632
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
